Muñoz-Torres M - Search Results

1

The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women.

Mezquita-Raya P, de la Higuera M, García DF, Alonso G, Ruiz-Requena ME, de Dios Luna J, Escobar-Jiménez F, Muñoz-Torres M. Mezquita-Raya P, et al. Osteoporos Int. 2005 Nov;16(11):1368-74. doi: 10.1007/s00198-005-1844-1. Epub 2005 Feb 12. Osteoporos Int. 2005. PMID: 15711777

2

[Prevalence of vitamin D deficiency in populations at risk for osteoporosis: impact on bone integrity].

Mezquita Raya P, Muñoz Torres M, López Rodríguez F, Martínez Martín N, Conde Valero A, Ortego Centeno N, González Calvín J, Raya Alvarez E, Luna Jd Jde D, Escobar Jiménez F. Mezquita Raya P, et al. Med Clin (Barc). 2002 Jun 22;119(3):85-9. doi: 10.1016/s0025-7753(02)73327-7. Med Clin (Barc). 2002. PMID: 12106535 Spanish.

3

[Advances in ostheochlast biology: the osteoprotegerin-RANK ligand system].

Muñoz-Torres M, de la Higuera López-Frías M, Fernández García D. Muñoz-Torres M, et al. Med Clin (Barc). 2004 Jan 24;122(2):75-7. doi: 10.1016/s0025-7753(04)74146-9. Med Clin (Barc). 2004. PMID: 14733862 Review. Spanish.

4

Susceptibility for postmenopausal osteoporosis: interaction between genetic, hormonal and lifestyle factors.

Mezquita-Raya P, Muñoz-Torres M, Alonso G, de Luna JD, Quesada JM, Dorado G, Luque-Recio F, Ruiz-Requena ME, Lopez-Rodriguez F, Escobar-Jiménez F. Mezquita-Raya P, et al. Calcif Tissue Int. 2004 Nov;75(5):373-9. doi: 10.1007/s00223-004-0187-9. Epub 2004 Jul 30. Calcif Tissue Int. 2004. PMID: 15592793

5

Calcitonin therapy in osteoporosis.

Muñoz-Torres M, Alonso G, Raya MP. Muñoz-Torres M, et al. Treat Endocrinol. 2004;3(2):117-32. doi: 10.2165/00024677-200403020-00006. Treat Endocrinol. 2004. PMID: 15743107 Review.

6

[Anabolic therapy of osteoporosis].

Fernández-García D, Alonso G, Muñoz-Torres M. Fernández-García D, et al. Med Clin (Barc). 2005 Sep 17;125(9):341-5. doi: 10.1157/13078782. Med Clin (Barc). 2005. PMID: 16185635 Review. Spanish.

7

Lactose intolerance revealed by severe resistance to treatment with levothyroxine.

Muñoz-Torres M, Varsavsky M, Alonso G. Muñoz-Torres M, et al. Thyroid. 2006 Nov;16(11):1171-3. doi: 10.1089/thy.2006.16.1171. Thyroid. 2006. PMID: 17123345

8

[Hypophosphatasia: new therapeutic approaches].

Alonso G, Varsavsky M, Muñoz-Torres M. Alonso G, et al. Med Clin (Barc). 2009 Jan 31;132(3):108-11. doi: 10.1016/j.medcli.2008.09.010. Epub 2009 Jan 24. Med Clin (Barc). 2009. PMID: 19211064 Review. Spanish.

9

Bone mineral density and risk of fractures in aging, obese post-menopausal women with type 2 diabetes. The GIUMO Study.

Sosa M, Saavedra P, Jódar E, Lozano-Tonkin C, Quesada JM, Torrijos A, Pérez-Cano R, Nogués X, Díaz-Curiel M, Moro MJ, Gómez C, Mosquera J, Alegre J, Olmos J, Muñoz-Torres M, Guañabens N, Del Pino J, Hawkins F; GIUMO Study Group. Sosa M, et al. Aging Clin Exp Res. 2009 Feb;21(1):27-32. doi: 10.1007/BF03324895. Aging Clin Exp Res. 2009. PMID: 19225266

10

Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappaB in women with postmenopausal osteoporosis.

Reyes-García R, Muñoz-Torres M, García DF, Mezquita-Raya P, García Salcedo JA, de Dios Luna J. Reyes-García R, et al. Menopause. 2010 Jan-Feb;17(1):140-4. doi: 10.1097/gme.0b013e3181ac0cc1. Menopause. 2010. PMID: 19574937

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293 results

Search Page

Filters